167 related articles for article (PubMed ID: 2508265)
1. Expression and immunogenicity of HLA-B27 in high-transfection recipient P815: a new method to induce monoclonal antibodies directed against HLA-B27.
Thurau SR; Wildner G; Kuon W; Weiss EH; Riethmüller G
Tissue Antigens; 1989 May; 33(5):511-9. PubMed ID: 2508265
[TBL] [Abstract][Full Text] [Related]
2. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
Galocha B; López D; López de Castro JA
J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
[TBL] [Abstract][Full Text] [Related]
3. Avidity dictates the lytic capacity of human cytolytic T lymphocyte clones with similar fine specificity against murine cells expressing HLA-B27 antigen.
Calvo V; Rojo S; Aparicio P; Galocha B; López de Castro JA
J Immunol; 1988 Dec; 141(11):3798-803. PubMed ID: 2460549
[TBL] [Abstract][Full Text] [Related]
4. Recognition of chlamydial antigen by HLA-B27-restricted cytotoxic T cells in HLA-B*2705 transgenic CBA (H-2k) mice.
Kuon W; Lauster R; Böttcher U; Koroknay A; Ulbrecht M; Hartmann M; Grolms M; Ugrinovic S; Braun J; Weiss EH; Sieper J
Arthritis Rheum; 1997 May; 40(5):945-54. PubMed ID: 9153558
[TBL] [Abstract][Full Text] [Related]
5. Human T cell recognition of cloned HLA class I gene products expressed on DNA transfectants of mouse mastocytoma P815.
Maryanski JL; Moretta A; Jordan B; De Plaen E; Van Pel A; Boon T; Cerottini JC
Eur J Immunol; 1985 Nov; 15(11):1111-7. PubMed ID: 2933264
[TBL] [Abstract][Full Text] [Related]
6. The use of fusion proteins to study HLA-B27-specific allorecognition.
Wildner G; Weiss EH; Szöts H; Riethmüller G; Schendel DJ
Mol Immunol; 1989 Jan; 26(1):33-40. PubMed ID: 2467195
[TBL] [Abstract][Full Text] [Related]
7. Modulation on immunogenicity by HLA-B27 subtype polymorphism.
Jaraquemada D; Galocha B; Aparicio P; Rojo S; Calvo V; López de Castro JA
Eur J Immunol; 1988 Dec; 18(12):1945-50. PubMed ID: 2464494
[TBL] [Abstract][Full Text] [Related]
8. HLA antibody responses in HLA class I transgenic mice.
Tahara T; Yang SY; Khan R; Abish S; Hämmerling GJ; Hämmerling U
Immunogenetics; 1990; 32(5):351-60. PubMed ID: 2249882
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
López D; Barber DF; Villadangos JA; López de Castro JA
J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
[TBL] [Abstract][Full Text] [Related]
10. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells.
Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG
J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902
[TBL] [Abstract][Full Text] [Related]
11. A patient-derived cytotoxic T-lymphocyte clone and two peptide-dependent monoclonal antibodies recognize HLA-B27-peptide complexes with low stringency for peptide sequences.
Huang F; Hermann E; Wang J; Cheng XK; Tsai WC; Wen J; Kuipers JG; Kellner H; Ackermann B; Roth G; Williams KM; Yu DK; Raybourne RB
Infect Immun; 1996 Jan; 64(1):120-7. PubMed ID: 8557329
[TBL] [Abstract][Full Text] [Related]
12. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
Yannelli JR; Moore LC; Engelhard VH
J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
[TBL] [Abstract][Full Text] [Related]
13. Epitope analysis of an HLA-B27-derived synthetic peptide: a possible approach to analyzing HLA class I antigens.
Zhao YP; Shi BJ; Deng HK; Yu DT; Hamachi M; Hamachi T; Zhao DF; Tang SR; Tsang JC; Park MS
Clin Exp Rheumatol; 1991; 9(3):235-9. PubMed ID: 1715248
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity among evolutionarily distant major histocompatibility complex class I molecules (HLA-B27 and H-2Kk) revealed by xenoreactive T lymphocytes.
Frangoulis B; Reboul M; Rocca A; Pla M
Eur J Immunol; 1993 Feb; 23(2):338-42. PubMed ID: 8436169
[TBL] [Abstract][Full Text] [Related]
15. Delineation of determinants on HLA-B7 and HLA-B27 that are necessary for cytolytic T cell recognition by using inter- and intra-domain recombinants.
Healy F; Toubert A; Gomard E; Jordan BR; Levy JP
J Immunol; 1989 Oct; 143(7):2357-63. PubMed ID: 2476507
[TBL] [Abstract][Full Text] [Related]
16. Four cytotoxic human-human hybridoma antibodies that react with HLA-B27.
Hansen T; Bratlie A; Hannestad K
Tissue Antigens; 1988 Nov; 32(5):267-77. PubMed ID: 2464858
[TBL] [Abstract][Full Text] [Related]
17. Conservation and alteration of HLA-B27-specific T cell epitopes on mouse cells. Implications for peptide-mediated alloreactivity.
Rojo S; López D; Calvo V; López de Castro JA
J Immunol; 1991 Jan; 146(2):634-42. PubMed ID: 1702810
[TBL] [Abstract][Full Text] [Related]
18. Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicity.
Aparicio P; Jaraquemada D; López de Castro JA
J Exp Med; 1987 Feb; 165(2):428-43. PubMed ID: 3102669
[TBL] [Abstract][Full Text] [Related]
19. A monospecific HLA-B27 fluorescein isothiocyanate-conjugated monoclonal antibody for rapid, simple and accurate HLA-B27 typing.
Pei R; Arjomand-Shamsai M; Deng CT; Cesbron A; Bignon JD; Lee JH
Tissue Antigens; 1993 Apr; 41(4):200-3. PubMed ID: 8362412
[No Abstract] [Full Text] [Related]
20. The epitope recognized by pan-HLA class I-reactive monoclonal antibody W6/32 and its relationship to unusual stability of the HLA-B27/beta2-microglobulin complex.
Tran TM; Ivanyi P; Hilgert I; Brdicka T; Pla M; Breur B; Flieger M; Ivasková E; Horejsí V
Immunogenetics; 2001 Aug; 53(6):440-6. PubMed ID: 11685454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
